Transcatheter Mitral Valve Repair Simulator Equipped with Eye Tracking Based Performance Assessment Capabilities: A Pilot Study.


Journal

Cardiovascular engineering and technology
ISSN: 1869-4098
Titre abrégé: Cardiovasc Eng Technol
Pays: United States
ID NLM: 101531846

Informations de publication

Date de publication:
10 2021
Historique:
received: 16 12 2020
accepted: 17 05 2021
pubmed: 9 6 2021
medline: 26 10 2021
entrez: 8 6 2021
Statut: ppublish

Résumé

The increase in cardiovascular disease cases that require minimally invasive treatment is inducing a new need to train physicians to perform them safely and effectively. Nevertheless, adaptation to simulation-based training has been slow, especially for complex procedures. We describe a newly developed mitral valve repair (MVR) simulator, equipped with new objective performance assessment methods, with an emphasis on its use for training the MitraClip™ procedure. The MVR contains phantoms of all anatomical structures encountered during mitral valve repair with a transvenous, transseptal approach. In addition, several cameras, line lasers, and ultraviolet lights are used to mimic echocardiographic and fluoroscopic imaging and with a remote eye tracker the cognitive behaviour of the operator is recorded. A pilot study with a total of 9 interventional cardiologists, cardiac surgeons and technical experts was conducted. All participants performed the MitraClip procedure on the MVR simulator using standard interventional tools. Subsequently, each participant completed a structured questionnaire to assess the simulator. The simulator functioned well, and the implemented objective performance assessment methods worked reliably. Key performance metrics such as x-ray usage were comparable with results from studies assessing these metrics in real interventions. Fluoroscopy imaging is realistic for the transseptal puncture but reaches its limits during the final steps of the procedure. The functionality and objective performance assessment of the MVR simulator were demonstrated. Especially for complex procedures such as the MitraClip procedure, this simulator offers a suitable platform for risk-free training and education.

Sections du résumé

BACKGROUND
The increase in cardiovascular disease cases that require minimally invasive treatment is inducing a new need to train physicians to perform them safely and effectively. Nevertheless, adaptation to simulation-based training has been slow, especially for complex procedures.
OBJECTIVES
We describe a newly developed mitral valve repair (MVR) simulator, equipped with new objective performance assessment methods, with an emphasis on its use for training the MitraClip™ procedure.
METHODS
The MVR contains phantoms of all anatomical structures encountered during mitral valve repair with a transvenous, transseptal approach. In addition, several cameras, line lasers, and ultraviolet lights are used to mimic echocardiographic and fluoroscopic imaging and with a remote eye tracker the cognitive behaviour of the operator is recorded. A pilot study with a total of 9 interventional cardiologists, cardiac surgeons and technical experts was conducted. All participants performed the MitraClip procedure on the MVR simulator using standard interventional tools. Subsequently, each participant completed a structured questionnaire to assess the simulator.
RESULTS
The simulator functioned well, and the implemented objective performance assessment methods worked reliably. Key performance metrics such as x-ray usage were comparable with results from studies assessing these metrics in real interventions. Fluoroscopy imaging is realistic for the transseptal puncture but reaches its limits during the final steps of the procedure.
CONCLUSION
The functionality and objective performance assessment of the MVR simulator were demonstrated. Especially for complex procedures such as the MitraClip procedure, this simulator offers a suitable platform for risk-free training and education.

Identifiants

pubmed: 34100226
doi: 10.1007/s13239-021-00549-4
pii: 10.1007/s13239-021-00549-4
pmc: PMC8481152
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

530-538

Informations de copyright

© 2021. The Author(s).

Références

Int J Otolaryngol. 2017;2017:2707690
pubmed: 28553354
J Surg Educ. 2014 Mar-Apr;71(2):193-7
pubmed: 24602709
Surgeon. 2007 Apr;5(2):81-5; quiz 85, 121
pubmed: 17450688
J Endourol. 2007 Mar;21(3):244-7
pubmed: 17444766
Surgery. 2010 May;147(5):622-30
pubmed: 20015529
Invest Radiol. 2020 Jul;55(7):457-462
pubmed: 32149859
Br J Surg. 1997 Feb;84(2):273-8
pubmed: 9052454
J Thorac Cardiovasc Surg. 2018 Feb;155(2):824-829
pubmed: 29221739
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1342-1352
pubmed: 31320029
Am J Phys Med Rehabil. 2001 Oct;80(10):717
pubmed: 11562551
Gynecol Surg. 2017;14(1):18
pubmed: 28959176
J Am Coll Radiol. 2010 Mar;7(3):192-7
pubmed: 20193924
Catheter Cardiovasc Interv. 2020 May 1;95(6):1202-1209
pubmed: 31531936
Int Surg. 2015 Feb;100(2):350-7
pubmed: 25692441
Med Educ. 2019 Jan;53(1):86-94
pubmed: 30216508

Auteurs

Jan Michael Zimmermann (JM)

Product Development Group Zurich, Department of Mechanical and Process Engineering, ETH Zurich, Tannenstrasse 3, CLA G17.2, 8092, Zurich, Switzerland. zimjan@ethz.ch.

Mattia Arduini (M)

Product Development Group Zurich, Department of Mechanical and Process Engineering, ETH Zurich, Tannenstrasse 3, CLA G17.2, 8092, Zurich, Switzerland.

Luca Vicentini (L)

Cardiac Surgery, University of Zurich, Zurich, Switzerland.

Francesco Maisano (F)

Cardiac Surgery, University of Zurich, Zurich, Switzerland.

Mirko Meboldt (M)

Product Development Group Zurich, Department of Mechanical and Process Engineering, ETH Zurich, Tannenstrasse 3, CLA G17.2, 8092, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH